LCN2 and inflammatory bowel disease: With the development of standardized protocols in future studies, one can envisage that the additional analysis of fecal lipocalin-2 levels could provide a diagnostic and prognostic advantage in comparison to the sole analysis of fecal calprotectin concentrations in inflammatory bowel diseases.